histidyl-aspartyl-glutamyl-leucine has been researched along with cyclopentane in 1 studies
| Studies (histidyl-aspartyl-glutamyl-leucine) | Trials (histidyl-aspartyl-glutamyl-leucine) | Recent Studies (post-2010) (histidyl-aspartyl-glutamyl-leucine) | Studies (cyclopentane) | Trials (cyclopentane) | Recent Studies (post-2010) (cyclopentane) |
|---|---|---|---|---|---|
| 17 | 0 | 2 | 10,498 | 86 | 5,283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Napier, JA; Richard, G; Shewry, PR; Turner, MF | 1 |
1 other study(ies) available for histidyl-aspartyl-glutamyl-leucine and cyclopentane
| Article | Year |
|---|---|
Trafficking of wheat gluten proteins in transgenic tobacco plants: gamma-gliadin does not contain an endoplasmic reticulum-retention signal.
Topics: Brefeldin A; Cyclopentanes; Endoplasmic Reticulum; Gliadin; Nicotiana; Oligopeptides; Plants, Genetically Modified; Plants, Toxic; Protein Sorting Signals; Protein Synthesis Inhibitors; Recombinant Fusion Proteins; RNA, Messenger; Transgenes; Triticum | 1997 |